PRICING ADDENDUM*
Dated April 2, 2024 to the
Pricing Supplement dated February 12, 2024
Filed Pursuant to Rule 424(b)(3)
Registration Statement No. 333-261476
(To Prospectus dated December 29, 2021,
Prospectus Supplement dated December 29, 2021,
Underlier Supplement dated December 29, 2021
and Product Supplement dated December 29, 2021)
|
Investment Description
|
• |
If the underlying performance factor is equal to or greater than 162% (meaning that the underlying performance factor is 162% or more, which equals an increase in the
final level of at least 62% from the initial level), BNS will pay you a cash payment per Security at maturity resulting in a return equal to the maximum gain of 102.60%.
|
• |
If the underlying performance factor is equal to or greater than 102% and less than 162%, BNS will pay you a cash payment per Security at maturity resulting in a return
equal to the sum of (a) 1.66 times the difference between the underlying performance factor and 102%, plus (b) 3.00%.
|
• |
If the underlying performance factor is equal to or greater than 96% and less than 102%, BNS will pay you a cash payment per Security at maturity resulting in a return
equal to 0.50 times the difference between the underlying performance factor and 96%.
|
• |
If the underlying performance factor is less than 96% and equal to or greater than 88% (which equals a decrease in the final level by more than 4% but by no more than 12%
from the initial level), BNS will pay you a cash payment per Security at maturity that is less than the principal amount, resulting in a percentage loss on your investment in the Securities equal to 1.50 times
the difference between the underlying performance factor and 96%. You will suffer a loss of 1.50% of your principal amount for each 1% that the underlying performance factor is less than 96%.
|
• |
If the underlying performance factor is less than 88%, BNS will pay you a cash payment per Security at maturity that is less than the principal amount, resulting in a
percentage loss on your investment in the Securities equal to the percentage that the underlying performance factor is less than 100%. In extreme situations, you could lose all of your investment in the Securities.
|
Features |
☐
|
Exposure to Performance of the Underlying Asset up to the Maximum Gain: If the underlying performance factor is at least 96%, at maturity
the Securities will provide a positive return based on the excess of the underlying performance factor over 96% and otherwise as described in the accompanying pricing supplement, subject to the maximum gain.
|
☐
|
Potential for Full Downside Market Exposure: If the underlying performance factor is less than
96%, which equals a decrease from the initial level to the final level of more than 4%, BNS will pay you a cash payment per Security at maturity that is less than the principal amount:
|
o
|
If the underlying performance factor is less than 96% but equal to or greater than 88% (meaning that there is a decrease from the initial level to the final level of more than 4% but equal to or less than 12%), the percentage loss on your investment in the Securities will be equal to 1.50 times
the difference between the underlying performance factor and 96%. In this scenario, you will suffer a loss of 1.50% for each 1% that the underlying performance factor is less than 96%.
|
o
|
If the underlying performance factor is less than 88% (meaning that there is a decrease from the initial level to the
final level of more than 12%), the percentage loss on your investment will be equal to the percentage that the underlying performance factor is less than 100%. In other words, you will be fully exposed to the negative
performance of the underlying asset from the initial level to the final level and, in extreme situations, you could lose all of your investment in the Securities. The contingent
repayment of principal applies only if you hold the Securities to maturity. Any payment on the Securities, including any repayment of principal, is subject to the creditworthiness of BNS.
|
Key Dates |
Initial Valuation Period
|
February 9, 2024 through April 2, 2024 (inclusive)
|
|
Trade Date
|
February 12, 2024
|
|
Settlement Date
|
February 15, 2024
|
|
Final Valuation Period*
|
December 24, 2029 through Final Valuation Date (inclusive)
|
|
Final Valuation Date*
|
March 26, 2030
|
|
Maturity Date*
|
March 29, 2030
|
Notice to investors: the Securities are significantly riskier than conventional debt instruments. The issuer is not necessarily obligated to repay the
principal amount of the Securities at maturity, and the Securities may have the same downside market risk as that of an investment in the underlying asset. This market risk is in addition to the credit risk inherent in purchasing a debt
obligation of BNS.
You should carefully consider the risks described under “Key Risks” beginning on page P-4 of the accompanying pricing supplement and under “Additional Risk Factors
Specific to the Notes” beginning on page PS-6 of the accompanying product supplement and “Risk Factors” beginning on page S-2 of the accompanying prospectus supplement and on page 7 of the accompanying prospectus. Events relating to any
of those risks, or other risks and uncertainties, could adversely affect the market value of, and the return on your Securities. You may lose some or all of your investment in the Securities in the Securities. The Securities will not be
listed or displayed on any securities exchange or any electronic communications network.
|
Security Offering
|
Underlying Asset
|
Bloomberg Ticker
|
Maximum Gain
|
Maximum Payment at Maturity
|
Initial Level
|
CUSIP
|
ISIN
|
Dow Jones Industrial Average®
|
INDU
|
102.60%
|
$20.26 per Security
|
38,993.85
|
06418H329
|
US06418H3295
|
Offering of Securities
|
Issue Price to Public
|
Underwriting Discount(1)(2)
|
Proceeds to The Bank of Nova Scotia(1)(2)
|
||||
Total
|
Per Security
|
Total
|
Per Security
|
Total
|
Per Security
|
||
Securities linked to the Dow Jones Industrial Average®
|
$3,000,000.00
|
$10.00
|
$7,500.00
|
$0.025
|
$2,992,500.00
|
$9.975
|
(1) |
Scotia Capital (USA) Inc. (“SCUSA”), our affiliate, has agreed to purchase the Securities at the principal amount and, as part of the distribution of the Securities, has agreed to sell the Securities to UBS
Financial Services Inc. (“UBS”) at the discount specified in the table above. See “Supplemental Plan of Distribution (Conflicts of Interest); Secondary Markets (if any)” in the accompanying pricing supplement for additional information.
|
(2) |
This amount excludes any profits to BNS, SCUSA or any of our other affiliates from hedging. See “Key Risks” and “Supplemental Plan of Distribution (Conflicts of Interest); Secondary Markets (if any)” in the
accompanying pricing supplement for additional considerations relating to hedging activities.
|
* |
This pricing addendum specifies the initial level for the Securities’ underlying asset and supplements the accompanying pricing supplement dated February 12, 2024 and the accompanying product supplement,
underlier supplement, prospectus supplement and prospectus. The Securities have the terms specified in these documents. See “Additional Information about BNS and the Securities” herein.
|
Scotia Capital (USA) Inc.
|
UBS Financial Services Inc.
|
Additional Information about BNS and the Securities
|
♦ |
Pricing Supplement dated February 12, 2024
|
♦ |
Product Supplement (Market-Linked Notes, Series A) dated December 29, 2021:
|
♦ |
Underlier Supplement dated December 29, 2021:
|
♦ |
Prospectus Supplement dated December 29, 2021:
|
♦ |
Prospectus dated December 29, 2021:
|